NCT07439731

Brief Summary

  1. 1.Study Purpose The primary aim of this research was to systematically describe and characterize a novel, thrombus-mimicking artifact observed during Intracardiac Echocardiography (ICE), termed the "Floating Lotus" sign. The study sought to define its imaging features, determine its prevalence, and identify the clinical factors that predict its occurrence. This was driven by the clinical need to prevent the misdiagnosis of this pseudo-thrombus as a true Left Atrial Appendage (LAA) thrombus, which could lead to unnecessary procedure cancellations or anticoagulation changes.
  2. 2.Study Population The study population consisted of 172 consecutive patients with non-valvular atrial fibrillation (AF) who underwent ICE-guided catheter ablation and/or left atrial appendage occlusion (LAAO) between January and December 2024 across three tertiary medical centers. Patients with confirmed intracardiac thrombus, significant valvular heart disease, or prior cardiac surgery were excluded.
  3. 3.Key Research Focus

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
172

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

February 23, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 27, 2026

Completed
Last Updated

February 27, 2026

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

February 23, 2026

Last Update Submit

February 23, 2026

Conditions

Keywords

Atrial fibrillationCatheter rotation maneuverPseudo-thrombusIntracardiac echocardiography

Outcome Measures

Primary Outcomes (1)

  • Incidence of the "Floating Lotus" Sign

    Intraoperative

Secondary Outcomes (2)

  • Independent Predictors of the "Floating Lotus" Sign

    Preoperative baseline

  • Determinants of Left Atrial Appendage (LAA) Emptying Velocity

    Intraoperative

Interventions

The core of this procedure is to perform a characteristic catheter operation on the basis of routine ICE scanning of the left atrial appendage: when an unclear, movable, chaotic echogenic mass (suspected thrombus) is observed in the standard plane, the operator needs to slowly and continuously rotate the ICE catheter clockwise. This dynamic maneuver aims to induce morphological changes in the echogenic mass, observe whether it merges with the left atrial appendage wall and reveals the underlying pectinate muscle structure, thereby confirming it as a pericardial effusion-related floating artifact (i.e., the 'Floating Lotus' sign), rather than a true intracavitary thrombus.

Also known as: Catheter Rotation Maneuver for Pseudo-Thrombus Differentiation

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population was derived from patients with atrial fibrillation who consecutively underwent intracardiac echocardiography (ICE)-guided catheter ablation and/or left atrial appendage occlusion (LAAO) between January and December 2024 at three tertiary medical centers in China.

You may qualify if:

  • Patients with a confirmed diagnosis of non-valvular atrial fibrillation (paroxysmal or persistent).
  • Completion of complete intracardiac echocardiography (ICE) imaging during the catheter ablation or left atrial appendage occlusion (LAAO) procedure.

You may not qualify if:

  • Confirmed intracardiac thrombus on pre-procedural transesophageal echocardiography (TEE) or left atrial computed tomography angiography (CTA).
  • Significant valvular heart disease (moderate or severe stenosis/regurgitation) or a history of cardiac surgery.
  • Incomplete clinical or imaging data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The First Affiliated Hospital of Naval Medical University (Shanghai Changhai Hospital)

Shanghai, Shanghai Municipality, 200433, China

Location

Shanghai Shidong Hospital, Yangpu District

Shanghai, Shanghai Municipality, 200438, China

Location

MeSH Terms

Conditions

Atrial Fibrillation

Interventions

Ice

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

WaterHydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen CompoundsEnvironmentEcological and Environmental PhenomenaBiological PhenomenaWeatherMeteorological ConceptsEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2026

First Posted

February 27, 2026

Study Start

January 1, 2024

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

February 27, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

We plan to share fully de-identified individual participant data (IPD) that underlie the results reported in the primary publication of this study. This includes: Baseline demographic and clinical characteristics; Procedural echocardiographic parameters ; These data will be made available upon reasonable request to researchers whose proposed use has been approved by an independent review committee for legitimate scientific purposes. Data will be shared after the publication of the primary results, typically within 12 months. Data access requires a signed data use agreement to ensure compliance with ethical and privacy regulations.

Shared Documents
STUDY PROTOCOL
Time Frame
Available starting 12 months after publication of the primary results, for a duration of 12 months.
Access Criteria
Access granted only to qualified researchers upon reasonable request. Only de identified participant-leveldata will be shared. Requests are subject to sponsor approval.

Locations